Terms of Reference of the Audit Committee under the Board of Directors

2023-10-27

Overseas Regulatory Announcement-Announcement on Apixaban Tablets Obtained the D

2023-10-18

Announcement Notice of Board Meeting

2023-10-12

Overseas regulatory announcement-Announcement on Febuxostat Obtaining Notificat

2023-10-10

Monthly Return of Equity Issuer on Movements in Securities for the month ended 3

2023-10-09

Overseas Regulatory Announcement-Announcement on Drugs of Wholly-owned Subsidiar

2023-09-20

Monthly Return of Equity Issuer on Movements in Securities for the month ended 3

2023-09-01

Announcement Notice of Board Meeting

2023-08-14

Overseas Regulatory Announcement-Announcement on Alogliptin Benzoate Tablets Obt

2023-08-11

Supplemental Announcement In Relation To Annual Report For The Year Ended 31 Dec

2023-08-07